In addition to its involvement in cancer, mutations in the 3′-end processing enzymes, PARN and USB1, were implicated in the human diseases, dyskeratosis congenita (DC) and poikiloderma with neutropenia (PN), respectively (Table 1) [67,68,71]. Here, PARN is linked to dyskeratosis congenita.